Page last updated: 2024-10-24

butalbital and Pain

butalbital has been researched along with Pain in 2 studies

butalbital: management of butalbital withdrawal can be simplified by using a phenobarbital-loading protocol; RN given refers to parent cpd
butalbital : A member of the class of barbiturates that is barbituric acid in which the hydrogens at position 5 are substituted by an allyl group and an isobutyl group. Frequently combined with other medicines, such as aspirin, paracetamol and codeine, it is used for treatment of pain and headache.

Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.

Research Excerpts

ExcerptRelevanceReference
"According to the degree of importance to the combined analgesic effect, Ace > Caf > Bul; Ace showed a significant dose-response relationship, whereas in Caf and Bul, this relationship was not apparent."1.31Quantitative design of optimal analgesic combination of acetaminophen, caffeine, and butalbital. ( Gui, CQ; Sun, RY; Wang, XW; Zheng, QS, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sekhon, I1
Munjal, S1
Croker, B1
Johnson, RJ1
Ejaz, AA1
Zheng, QS1
Wang, XW1
Gui, CQ1
Sun, RY1

Other Studies

2 other studies available for butalbital and Pain

ArticleYear
Glomerular tip lesion associated with nonsteroidal anti-inflammatory drug-induced nephrotic syndrome.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 46, Issue:4

    Topics: Accidents, Traffic; Acetaminophen; Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Barbi

2005
Quantitative design of optimal analgesic combination of acetaminophen, caffeine, and butalbital.
    Acta pharmacologica Sinica, 2001, Volume: 22, Issue:8

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Barbiturates; Caffeine; Carrageenan; Dose-Response

2001